Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10528183rdf:typepubmed:Citationlld:pubmed
pubmed-article:10528183lifeskim:mentionsumls-concept:C1332717lld:lifeskim
pubmed-article:10528183lifeskim:mentionsumls-concept:C1706438lld:lifeskim
pubmed-article:10528183lifeskim:mentionsumls-concept:C0034790lld:lifeskim
pubmed-article:10528183lifeskim:mentionsumls-concept:C1155065lld:lifeskim
pubmed-article:10528183lifeskim:mentionsumls-concept:C0085358lld:lifeskim
pubmed-article:10528183lifeskim:mentionsumls-concept:C0037083lld:lifeskim
pubmed-article:10528183lifeskim:mentionsumls-concept:C0079717lld:lifeskim
pubmed-article:10528183lifeskim:mentionsumls-concept:C0542341lld:lifeskim
pubmed-article:10528183lifeskim:mentionsumls-concept:C0332197lld:lifeskim
pubmed-article:10528183lifeskim:mentionsumls-concept:C0205217lld:lifeskim
pubmed-article:10528183lifeskim:mentionsumls-concept:C1413244lld:lifeskim
pubmed-article:10528183lifeskim:mentionsumls-concept:C2698600lld:lifeskim
pubmed-article:10528183lifeskim:mentionsumls-concept:C1710082lld:lifeskim
pubmed-article:10528183pubmed:issue9lld:pubmed
pubmed-article:10528183pubmed:dateCreated1999-11-19lld:pubmed
pubmed-article:10528183pubmed:abstractTextSignaling through the TCR as well as engagement of costimulatory molecules are required for efficient T cell activation and progression into differentiated effector cells. The beta2 integrin LFA-1 (CD11a/CD18) has been implicated in TCR costimulation as well as in cell-cell adhesion function, but its exact role is still ambiguous. The present study focuses on the requirement for LFA-1 in CD8+ T cell activation and effector function using LFA-1-deficient cells expressing the 2C transgenic TCR as a model system. The lack of LFA-1 expression in 2C T cells resulted in severely diminished proliferative response toward allogeneic BALB/c splenocytes. Increase in TCR signaling alone by pulsing stimulators with high affinity peptides, p2Ca or QL9, had minimal effects in restoring proliferation. Addition of exogenous IL-2, however, enhanced the effect of peptide pulsing on proliferation of LFA-1-deficient 2C T cells. LFA-1-deficient 2C CTLs generated from alloantigen stimulation exhibited a defective cytotoxic activity when tested on a variety of target cells. Cytolysis could be improved, but not fully rectified by peptide pulsing of target cells. Thus, in the 2C TCR model, LFA-1 has a requisite role for optimal CD8+ T cell activation and effector function, which cannot be overcome by increasing peptide/MHC density on either the APCs or target cells, respectively.lld:pubmed
pubmed-article:10528183pubmed:languageenglld:pubmed
pubmed-article:10528183pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10528183pubmed:citationSubsetAIMlld:pubmed
pubmed-article:10528183pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10528183pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10528183pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10528183pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10528183pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10528183pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10528183pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10528183pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10528183pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10528183pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10528183pubmed:statusMEDLINElld:pubmed
pubmed-article:10528183pubmed:monthNovlld:pubmed
pubmed-article:10528183pubmed:issn0022-1767lld:pubmed
pubmed-article:10528183pubmed:authorpubmed-author:QuS FSFlld:pubmed
pubmed-article:10528183pubmed:authorpubmed-author:Fung-LeungW...lld:pubmed
pubmed-article:10528183pubmed:authorpubmed-author:ShierPPlld:pubmed
pubmed-article:10528183pubmed:issnTypePrintlld:pubmed
pubmed-article:10528183pubmed:day1lld:pubmed
pubmed-article:10528183pubmed:volume163lld:pubmed
pubmed-article:10528183pubmed:ownerNLMlld:pubmed
pubmed-article:10528183pubmed:authorsCompleteYlld:pubmed
pubmed-article:10528183pubmed:pagination4826-32lld:pubmed
pubmed-article:10528183pubmed:dateRevised2003-11-14lld:pubmed
pubmed-article:10528183pubmed:meshHeadingpubmed-meshheading:10528183...lld:pubmed
pubmed-article:10528183pubmed:meshHeadingpubmed-meshheading:10528183...lld:pubmed
pubmed-article:10528183pubmed:meshHeadingpubmed-meshheading:10528183...lld:pubmed
pubmed-article:10528183pubmed:meshHeadingpubmed-meshheading:10528183...lld:pubmed
pubmed-article:10528183pubmed:meshHeadingpubmed-meshheading:10528183...lld:pubmed
pubmed-article:10528183pubmed:meshHeadingpubmed-meshheading:10528183...lld:pubmed
pubmed-article:10528183pubmed:meshHeadingpubmed-meshheading:10528183...lld:pubmed
pubmed-article:10528183pubmed:meshHeadingpubmed-meshheading:10528183...lld:pubmed
pubmed-article:10528183pubmed:meshHeadingpubmed-meshheading:10528183...lld:pubmed
pubmed-article:10528183pubmed:meshHeadingpubmed-meshheading:10528183...lld:pubmed
pubmed-article:10528183pubmed:meshHeadingpubmed-meshheading:10528183...lld:pubmed
pubmed-article:10528183pubmed:meshHeadingpubmed-meshheading:10528183...lld:pubmed
pubmed-article:10528183pubmed:meshHeadingpubmed-meshheading:10528183...lld:pubmed
pubmed-article:10528183pubmed:meshHeadingpubmed-meshheading:10528183...lld:pubmed
pubmed-article:10528183pubmed:meshHeadingpubmed-meshheading:10528183...lld:pubmed
pubmed-article:10528183pubmed:meshHeadingpubmed-meshheading:10528183...lld:pubmed
pubmed-article:10528183pubmed:meshHeadingpubmed-meshheading:10528183...lld:pubmed
pubmed-article:10528183pubmed:meshHeadingpubmed-meshheading:10528183...lld:pubmed
pubmed-article:10528183pubmed:meshHeadingpubmed-meshheading:10528183...lld:pubmed
pubmed-article:10528183pubmed:meshHeadingpubmed-meshheading:10528183...lld:pubmed
pubmed-article:10528183pubmed:meshHeadingpubmed-meshheading:10528183...lld:pubmed
pubmed-article:10528183pubmed:meshHeadingpubmed-meshheading:10528183...lld:pubmed
pubmed-article:10528183pubmed:meshHeadingpubmed-meshheading:10528183...lld:pubmed
pubmed-article:10528183pubmed:year1999lld:pubmed
pubmed-article:10528183pubmed:articleTitleDefective CD8+ T cell activation and cytolytic function in the absence of LFA-1 cannot be restored by increased TCR signaling.lld:pubmed
pubmed-article:10528183pubmed:affiliationR. W. Johnson Pharmaceutical Research Institute, San Diego, CA 92121, USA.lld:pubmed
pubmed-article:10528183pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10528183lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10528183lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10528183lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10528183lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10528183lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10528183lld:pubmed